OrbiMed is a leading global investment firm dedicated exclusively to the healthcare sector. They invest across the entire industry spectrum, from venture capital in early-stage startups to growth equity and investments in large multinational corporations. Their multi-strategy approach, encompassing private equity, public equity, and royalty/credit opportunities, allows them to finance innovation at all stages of business development. This deep, singular focus on healthcare, combined with their global presence and flexible capital, defines their unique position as an investor.